Across large population cohorts, clonal haematopoiesis of indeterminate potential was linked to higher risk of chronic liver disease, including NASH. Specifically, LiverMultiScan findings in UK Biobank participants revealed a higher prevalence of liver disease activity and liver fat in individuals with CHIP. LiverMultiScan may represent a modifiable risk factor for e.g. blood cancers and cardiovascular disease.